Predictive value for mortality of left ventricular wall thickness in dilated cardiomyopathy

Jing Li1, Yue-Yue Feng1, Chun-Ai Hu2

  • 1Graduate School of Bengbu Medical College, Bengbu, Anhui, China.

ESC Heart Failure
|September 22, 2023
PubMed

Insights

Cardiac magnetic resonance (CMR) measurements of posterior wall thickness (PWT) predict mortality in dilated cardiomyopathy (DCM) patients. Lower PWT and relative PWT (RWTPW) are associated with increased all-cause death risk.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Predictive Analytics

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Accurate prognostication in DCM is crucial for patient management.
  • Cardiac magnetic resonance (CMR) offers detailed cardiac structure and function assessment.

Purpose of the Study:

  • To evaluate the predictive capability of cardiac magnetic resonance (CMR)-measured wall thickness for all-cause mortality in patients with dilated cardiomyopathy (DCM).

Main Methods:

  • Retrospective analysis of 161 DCM patients undergoing CMR.
  • Measurement of left ventricular dimensions, wall thickness (PWT, IVST), and mass.
  • Calculation of relative wall thickness (RWTPW, RWTIVS).
  • Assessment of late gadolinium enhancement (LGE).
  • Follow-up for all-cause mortality.

Main Results:

  • Posterior wall thickness (PWT) and relative posterior wall thickness (RWTPW) were significantly lower in patients who died.
  • PWT and RWTPW were identified as independent predictors of all-cause mortality via multivariate Cox regression.
  • Interventricular septum thickness (IVST), RWTIVS, and LGE presence did not show significant independent predictive value.

Conclusions:

  • Cardiac magnetic resonance (CMR)-derived posterior wall thickness (PWT) is a valuable independent predictor of all-cause mortality in DCM patients.
  • Septal wall thickness measurements did not demonstrate a significant correlation with mortality in this cohort.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14